Task: Answer the multiple choice question.
Query: Which drug exhibits a -15.428\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a. Cc1ccc(S(=O)(=O)N(C)C)cc1NC(=O)COC(=O)Cc1ccsc1
b. Cc1cc(N2CCOCC2)ccc1/C=C1\SC(=O)N(C(C)C)C1=O
Answer: b. Cc1cc(N2CCOCC2)ccc1/C=C1\SC(=O)N(C(C)C)C1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(N2CCOCC2)ccc1/C=C1\SC(=O)N(C(C)C)C1=O
Cc1cc(N2CCOCC2)ccc1/C=C1\SC(=O)N(C(C)C)C1=O
(5Z)-5-[(2-methyl-4-morpholin-4-ylphenyl)methylidene]-3-propan-2-yl-1,3-thiazolidine-2,4-dione